Skip to content

Peptide library / Heart & blood / Carperitide

FDA-approvedHeart & blood

Carperitide

A recombinant atrial natriuretic peptide used for acute heart failure in Japan.

Body system
Heart & blood
Status
FDA-approved
Strongest evidence
FDA approved
Also known as
Hanp

Effects studied or claimed

What it is used or promoted for, and where each effect has actually been seen

  • Acute heart failureFDA approved

How it is thought to work

Carperitide is a copy of the heart's own hormone that widens blood vessels and increases salt excretion.

What the evidence shows

Widely used in Japan, with observational evidence suggesting benefit when started early at low doses.

Safety and unknowns

Low blood pressure and worsening kidney function in some patients.

Regulatory status

Approved in Japan. Not approved by the FDA.

Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.

More in Heart & blood

General information, not medical advice. Do not buy or inject unregulated peptides.